mAbxience |

Cancer Chemotherapy and Pharmacology has published comparative data of rituximab biosimilar RTXM83R in lymphoma patients

03/06/2018

The journnal Cancer Chemotherapy and Pharmacology has recently published the randomized, double-blind, phase III and comparative clinical study of pharmacokinetics and pharmacodynamics between RTXM83™ rituximab biosimilar and its reference product in diffuse large B-cell lymphoma patients.  The main objective was to quantify any potential differences in pharmacokinetic (PK) parameters (AUC and Cmax). To demonstrate biosimilarity […]

2nd National Conference on Biosimilars

03/05/2018

mAbxience actively participated in the 2nd National Conference on Biosimilars organised by the Spanish Biosimilar Medicines Association, BioSim. The conference, entitled “Biosimilars: evidence and efficiency”, took place at the Ministry of Health, Social Services and Equality in Madrid on 21st February. Francisco Olivera, Operations Manager at mAbxience León, shared the “Evidence: from R&D to authorisation” […]

INSUD PHARMA is the new name of Chemo Group

11/24/2017

Therefore, our three pharma brands, Chemo, Exeltis and mAbxience, are now grouped together under this name. This new identity is the result of the development and diversification of the company’s pharma activity. Madrid, 24 November 2017–From now on, Chemo Group, the pharmaceutical multinational that is present in over 40 countries, is going to be called […]

Meet us at CPhI Worldwide!

09/17/2017

Meet us at CPhI Worldwide! Between 24th and 26th October the CPhI Worldwide Congress 2017 will take place in Frankfurt (Germany).   Details When? Between 24th and 26th October Where? Frankfurt (Germany)

mAbxience analyses getting a new plant in Argentina

07/31/2017

The company is part of the multinational CHEMO group, with 40 years’ experience in the pharmaceutical industry and presence in more than 40 countries. The biotechnology company dedicated to the R&D, manufacture and commercialisation of drugs, mainly biosimilars medicines, already has an R&D centre in Spain, together with a monoclonal antibody production plant in Munro, […]

BAC León 2017

07/13/2017

Between 12th and 14th July the Biotech Annual Congress (BAC) 2017 will take place in León (Spain), organised by FEBiotech, the Spanish Federation of Biotechnologists. This event offers a great meeting point of a high scientific level, bringing together Biotech students with researchers and professionals from different areas of this discipline.   Within the mentoring […]